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Operational research (OR) has become a hot topic at 
national meetings, international conferences and donor 
fora. The International Union Against Tuberculosis and 
Lung Disease (The Union) and Médecins Sans Frontières 
(MSF) Operational Centre Brussels strongly promote 
and implement OR with colleagues in low- and middle-
income countries. Here we describe how the two organi-
sations defi  ne OR, and explain the guiding principles 
and methodology that underpin the strategy for develop-
ing and expanding OR in those countries. We articulate 
The Union’s and MSF’s approach to supporting OR, high-
lighting the main synergies and differences. Then, using 
the Malawi National Tuberculosis Control Programme 
as an example, we show how OR can be embedded 
within tuberculosis control activities, leading to changes 
in policy and practice at the national level. We discuss 
the diffi  cult, yet vitally important, issue of capacity build-
ing, and share our vision of a new paradigm of product-
related training and performance-based OR fellowships 
as two ways of developing the necessary skills at country 
level to ensure research is actually performed. Finally, we 
highlight the need to consider and incorporate into prac-
tice the ethical components of OR. This is a key moment 
to be involved in OR. We are confi  dent that in partner-
ship with interested stakeholders, including the World 
Health Organization, we can stimulate the implementa-
tion of quality, relevant OR as an integral part of health 
service delivery that in turn will lead to better health for 
people, particularly for those living in the poorer parts 
of the world. 
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DEFINING THE TERM ‘OPERATIONAL 
RESEARCH’ 
If 10 different people are asked to defi  ne operational 
research (OR), there will probably be 10 different an-
swers. ‘Operational research’, also sometimes known 
as ‘operations research’, has been variously defi  ned as 
an interdisciplinary branch of applied mathematics or 
formal science that uses advanced analytic methods 
to make better decisions or research that provides op-
timal solutions to complex decision-making.1,2 The 
term ‘implementation research’ is also commonly used, 
and has been defi  ned by some as the scientifi  c study 
of methods to promote the systematic uptake of clini-
cal research fi  ndings and other evidence-based prac-
tices into routine practice, and hence to improve the 
quality (effectiveness, reliability, safety, appropriate-
ness, equity, effi  ciency) of health care.3,4 These various 
defi  nitions have a certain commonality. 
At the International Union Against Tuberculosis 
and Lung Disease (The Union) and the Médecins 
Sans Frontières (MSF), based on our shared experi-
ence, we have developed a more simple and pragmatic 
understanding of these types of research. We prefer 
the term ‘OR’, which we defi  ne as research into strate-
gies, interventions, tools or knowledge that can en-
hance the quality, coverage, effectiveness or perfor-
mance of the health system or programmes in which 
the research is being conducted.5 We see OR as a spec-
trum of activities that encompasses reviews of regis-
ters and treatment cards, minor modifi  cations  and 
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evaluations of operational practices to fi  eld testing 
new technologies. 
GUIDING PRINCIPLES AND 
RESEARCH METHODOLOGY
We have three guiding principles that underpin our 
way of conducting OR and help us to set up a re-
search agenda and determine research priorities. The 
fi  rst principle is that a health programme (or health 
system) should have well-defi   ned goals and objec-
tives. For example, for a tuberculosis (TB) control 
programme, these goals will often focus around case 
fi  nding and case holding/treatment, with objectives 
directed towards better and more equitable diagnosis, 
improved cure rates, low death rates, uninterrupted 
drug supplies and reliable monitoring. The second 
principle is that constraints and obstacles that prevent 
these objectives from being achieved must be identi-
fi  ed, prioritised and articulated. The third principle is 
that research questions need to be asked to address 
these constraints. The avenues of enquiry are usually 
of three main types—is there a lack of knowledge? a 
lack of a suitable tool or intervention or the possibil-
ity of a better tool or intervention being used? or an 
ineffi  cient use of a tool or intervention? Table 1 pro-
vides an example of how these guiding principles might 
work in a number of different programme settings.
OR is often observational in nature, and involves 
three main types of methodology: descriptive studies 
(sometimes called ‘cross-sectional research’ if it in-
cludes a strong analytic component), case-control stud-
ies, and retrospective or prospective cohort analysis 
studies. We do not regard basic science, experimental 
research or classical randomised controlled clinical 
trials (RCTs) as OR. Most RCTs determine the effi  cacy 
of an intervention in a strictly controlled environment 
with inclusion and exclusion criteria, while OR as-
sesses effectiveness within the routine programme 
setting. However, pragmatic randomised controlled 
designs, such as a cluster-randomised trial of commu-
nity support for human immunodefi  ciency virus (HIV) 
care,6 carried out within routine programme settings, 
might be included as OR. 
Both OR and the classical RCT play an important 
part in the generation of new knowledge: the RCT 
provides clear-cut data on effi  cacy in identifi  ed groups 
of patients, while OR determines the effectiveness of 
interventions in the real world of routine patient care. 
OR is often regarded as second best to the RCT, but 
each contributes to better patient care in its own way; 
in fact, they are complementary. Recent guidelines for 
the reporting of observational studies (the Strength-
ening the Reporting of Observational Studies in Epi-
demiology [STROBE] statement) will help towards 
improving the scientifi  c credibility and value of this 
type of research.7
Well-performing TB control or antiretroviral treat-
ment (ART) delivery programmes are well adapted 
for OR because of their strong, inherent standardised 
monitoring and evaluation systems. These systems 
routinely track the number of patients enrolled for 
treatment over defi   ned periods, key demographic 
and clinical characteristics, types of treatment and 
treatment outcomes. Such data, documented in treat-
ment cards and facility-based registers and sometimes 
within electronic data systems, are ideally suited for 
OR. Furthermore, conducting OR using programme 
data invariably has a benefi  cial effect on data collec-
tion and quality. Linking monitoring and evaluation 
data to OR is thus a win-win situation, which should 
lead to better quality monitoring and research and 
ultimately to improved programme performance.
THE UNION’S APPROACH TO OPERATIONAL 
RESEARCH SUPPORT IN TB CONTROL
In the last 10–15 years, there have been impressive 
gains in global TB control, with gradual increases 
in case detection and treatment success rates.8 How-
ever, many challenges remain, including access to 
early diagnosis, implementing programmatic manage-
ment of multidrug-resistant TB (MDR-TB) and HIV-
associated TB and the effi  cient and informed introduc-
tion of new diagnostic tools into routine programme 
settings. These are all priority issues that could benefi  t 
from timely and pragmatic OR studies. While OR has 
been included in the most recent Global Plan to Stop 
TB (2006–2015),9 actual implementation of research 
activities in the fi  eld for various reasons, such as lack 
of capacity and diffi   culty in formulating research 
Table 1  An example of the process of developing an 
operational research study
Type of setting TB programme
HIV treatment programme
Smoking cessation intervention
Objective 85% treatment success in TB programme
80% retention on antiretroviral treatment 
90% successful completion in smoking 
cessation cohort
Constraint High rates of loss to follow-up
Research question Why are patients lost to follow-up?
Research 
 methodology
Involves identifying and tracing patients lost 
to follow-up:
•  Review of clinic and laboratory registers
•  Active tracing to determine how many of 
those lost to follow-up are unreported 
deaths, un-notiﬁ  ed transfer outs, patients 
who have stopped treatment or patients 
who are still on treatment but from other 
sources
•  Qualitative research to determine why 
patients have stopped treatment—Payment 
for medication? Cost of transport to clinic?
Answers to the 
 question
The programme seeks to solve the problems 
and reduce losses to follow-up and 
ultimately improve treatment outcomes.
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questions, has not been systematically developed in 
many of the high-burden countries most in need of 
these efforts. 
The Union is currently trying to address these defi  -
ciencies through two independent, yet interlinked, 
research initiatives. In September 2008, through re-
sources awarded by the United States Agency for Inter-
national Development (USAID), The Union launched 
the TREAT TB (Technology, Research, Education and 
Technical Assistance for TB) Initiative. This initia-
tive aims to address specifi  c research gaps globally in 
the area of diagnosis and treatment of TB, and build 
OR and programme assessment capacity at country 
level among ministries of health and their National 
TB Programmes (NTPs) in USAID-priority countries. 
Through this fi  ve-year initiative, The Union is engag-
ing with numerous technical partners working at in-
ternational, regional and national levels to achieve a 
number of objectives. One of these is to defi  ne and 
address priority needs for OR among NTPs and 
their local partners. In January 2009, through gener-
ous philanthropy, The Union was able to found the 
Centre for Operational Research, which aims to 
strengthen OR capacity and the collection and use of 
strategic information in low- and middle-income coun-
tries. Its focus is on TB and HIV/AIDS (acquired 
i  mmune-d  efi  ciency syndrome), key non-communicable 
diseases such as diabetes and hypertension, and moni-
toring methods that include the use of electronic med-
ical records to track chronic disease and village-level 
vital registration. 
OR is not new to The Union, however. Founded in 
its present form in 1920, The Union has had a long 
history of engagement in OR.10 The Union’s Board of 
Directors in 1987 approved the prioritisation of three 
main activities: education, research and technical as-
sistance. OR features in each of these priority activi-
ties. Consultants, with their colleagues in country pro-
grammes, currently publish about 50 OR articles per 
year. The Union also provides a platform for exchanges 
about OR through its international and regional con-
ferences and through the scientifi  c journal, the Inter-
national Journal of Tuberculosis and Lung Disease 
(IJTLD). 
Country-level needs have always been paramount 
in The Union’s thinking, and a comprehensive ap-
proach to support OR has been the predominant 
strategy. Figure 1 illustrates the comprehensive sup-
port package articulated by the TREAT TB Initiative. 
A necessary starting point is a situational analysis 
that provides a clear understanding of the existence 
or not of a research agenda; past and present OR ac-
tivities, including the identifi  cation of key national 
and international partners involved in OR; linkages 
between national academic institutions and govern-
ment programmes; human and fi  nancial resource ca-
pacity to undertake OR; and past publications and 
policy changes related to national research efforts. 
Countries and programmes vary in their OR achieve-
ments at the time that this analysis is undertaken, 
with some programmes having virtually no OR ca-
pacity while others may be fairly experienced. This 
analysis also serves as a baseline against which annual 
evaluations and assessments of OR activities can be 
conducted, and it also allows for the development of 
a coordinated plan for OR.
The next important step is the clarifi  cation of pro-
gramme objectives and the development of clearly 
defi  ned priorities, which often require a broad consul-
tation process with local and international partners. 
Where a priority setting exercise has already taken 
place, updates may be necessary at regular intervals to 
ensure the greatest relevance of OR activities on an 
ongoing basis. Situational analyses, clarifi  cation  of 
programme objectives and priority setting activities 
are helpful steps to identify OR agendas and training 
plans that are tailored to national needs. Related to, 
yet distinct from the broad training requirements for 
successful OR at country level, is the need for leader-
ship in the management of research programmes. This 
capacity can be developed through a variety of inter-
national training and mentoring opportunities, in-
cluding support and training for OR fellows.
The presence of clearly established research priori-
ties and adequate human resources at all levels are 
necessary, but not suffi  cient, components for success-
ful OR implementation. Funding is required, and The 
Union supports countries and programmes in identi-
fying and securing the necessary fi  nancial resources to 
address national research priorities. Moreover, The 
Union provides comprehensive guidance for all as-
pects of OR, including protocol development, ethics 
review processes through to peer-reviewed publica-
tions and presentations and knowledge translation. 
A unique aspect of The Union’s OR package is the 
inclusion of two new frameworks in its training and 
OR initiatives. The impact analysis framework (IAF) 
developed by the Liverpool School of Tropical Medi-
cine and partners, and being tested, in part, through 
The Union-led TREAT TB Initiative, examines new 
tools and approaches through a broad lens.11 It moves 
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beyond simply an analysis of effi  cacy, adding further 
analyses related to equity, health systems, scale-up 
and policy. It is accompanied by a policy transfer 
analysis framework developed by The Union. Policy 
transfer analysis adds a further dimension to OR by 
assessing the factors that affect uptake into policy and 
practice and the impact of OR on national policy.
MÉDECINS SANS FRONTIÈRE’S APPROACH 
TO OPERATIONAL RESEARCH 
MSF is an international medical non-governmental 
organisation (NGO) that works in many countries 
and provides medical assistance to vulnerable popu-
lations living in diffi  cult and resource-limited settings. 
Over the past 10 years, the organisation has become 
increasingly involved in disease control programmes 
such as HIV/AIDS, TB and malaria. Unlike at The 
Union, OR in MSF is rather new. There was a time 
when research was considered taboo by senior man-
agers, who felt it to be in confl  ict with the core ‘imple-
mentation’ mandate of the organisation and a possi-
ble diversion of operational resources. However, this 
attitude has changed with the realisation that research 
can be complementary to project goals and can sup-
port the mandate of the organisation. 
The three main reasons why MSF now embraces 
OR are 1) to assess the effectiveness of treatment or 
prevention interventions in projects, thereby leading 
to improvements in the quality of the assistance; 2) to 
assess the feasibility of implementing new models of 
care; and 3) to gather evidence to support advocacy 
for health policy change.12 Although the basic princi-
ples upon which The Union and MSF have built their 
research foundations are synergistic, there are some 
differences related to the mandates of the two organi-
sations that are worthy of note. 
First, as an implementing organisation, MSF di-
rectly implements research on the ground. The project 
medical coordinator is held responsible, enhancing 
ownership and helping to make research an integral 
part of routine operational activity. 
Second, programme offi  cers help to defi  ne the re-
search questions based on monitoring and evaluation 
data. Studies are therefore often descriptive or cohort 
in nature, and involve routine programme data.12 
Eight of 10 studies conducted by MSF fall into this 
category, with prospective studies and clinical trials 
constituting a minority of 6%.12 MSF rarely conducts 
clinical trials, as it is not resourced to do so and has 
no comparative advantages over academic or other 
research institutions in this regard. Previous experi-
ence with RCTs within MSF has also shown that these 
can become a parallel activity with routine opera-
tions, and this risks a confl  ict with the core implemen-
tation mandate of the organisation. 
Third, research studies generated from programme 
data are incorporated into annual project planning 
exercises where funding is an integral component. 
This facilitates administrative aspects, and means that 
researchers do not have to worry about securing ex-
ternal funding. 
Fourth, MSF’s research agenda is more diverse 
than that of The Union, as it is driven by changing 
operational projects. Until now, the focus at The 
Union has been centred on TB and respiratory dis-
ease, although this is changing. While a dynamic OR 
agenda in MSF keeps the focus congruent with opera-
tions, the downside is that research activities in spe-
cifi  c domains might not be sustained, and the exper-
tise needed might not necessarily be available within 
the organisation. Fifth, operational activity and ca-
pacity building are primarily focused at the district or 
project level, rather than at the national level as with 
The Union. However, it is through such decentralised 
modus operandi that technical and advocacy links are 
made to the central level and beyond. 
Finally, The Union hosts the IJTLD and dissemi-
nates knowledge on TB, lung health, HIV and to-
bacco control in this and a number of other journals. 
MSF also disseminates knowledge through publi-
cations in a variety of journals, but it also hosts the 
MSF Field Research Repository13 and conducts an-
nual scientifi  c days.14,15 The Field Research Reposi-
tory makes all MSF-authored, peer-reviewed pub-
lications available free-of-charge online thanks to 
permission granted by over 100 journals. A recent 
analysis of the repository showed that close to 130 
peer-reviewed publications are downloaded each day 
from different countries around the world, indicating 
the relevance and public demand for these publica-
tions. Table 2 highlights a number of examples of re-
search conducted by MSF, their main fi  ndings and 
implications for policy and practice.12,16–22 Table 3 
highlights some key enabling factors that have per-
mitted the development of research in MSF. How-
ever, it is important to note that this has not always 
been smooth sailing, and several barriers have been 
encountered along the way. Table 4 highlights some 
of these barriers, the possible reasons and lessons 
learnt.12 It is only by addressing such challenges and 
persevering that one can continue to ‘learn by doing’, 
and in this way fi  nd solutions. 
AN EXAMPLE OF INVESTING IN OPERATIONAL 
RESEARCH: THE MALAWI NATIONAL 
TB PROGRAMME
Between 1996 and 2004, the Malawi NTP, with sup-
port from the international donor community, in-
vested in OR as an integral part of its activities. A 
partnership was set up whereby research ideas from 
within the NTP, from local institutions (such as the 
Malawi Medical School, NGOs such as MSF and the 
National AIDS Programme) and from international or-
ganisations (such as the World Health Organization 148  The   International   Journal   of   Tuberculosis   and   Lung   Disease
[WHO], The Union and the Liverpool School of 
Tropical Medicine) were discussed and endorsed at 
the six-weekly meetings of the Malawi TB Programme 
Management Group. After priorities were established, 
research activities were then implemented by the vari-
ous stakeholders (Figure 2). Many were planned, ini-
tiated, completed and published within the Malawi 
NTP itself; the enabling factors that contributed to 
this achievement are listed in Table 5.23 At the end of 
every year, a report was written on research under-
taken, studies completed, studies published and the 
effect that these studies had on infl  uencing policy and 
practice.24,25
The success of OR was judged in various ways: 
1) whether proposed annual targets in terms of proj-
ects initiated, projects completed, papers written and 
papers published were met; 2) whether the research 
fi  ndings infl  uenced policy and practice; and 3) whether 
the research helped to improve programme perfor-
mance. The OR led to key changes in national policy 
and practice, examples of which included the cre-
ation of a prison tuberculosis control programme, 
which continues to this day,26,27 improved recording 
and reporting of patients with previously treated TB,28 
Table 2  Examples of operational research studies published by Médecins Sans Frontières and their contributions to policy and 
practice. Adapted from Zachariah et al.12
Operational research studies, author, 
reference, title Main ﬁ  nding(s)  Contribution(s) to policy and practice 
Improving effectiveness of medical interventions 
Zachariah et al.16 Payment for antiretroviral 
drugs is associated with a higher rate of 
patients lost to follow-up than those offered 
free-of-charge therapy in Nairobi, Kenya
Massaquoi et al.17 Patient retention and 
attrition on antiretroviral treatment at district 
level in rural Malawi
58% higher risk of loss to follow-
up associated with payment 
for ART; ART dose dilutions by 
patients who had to pay 
for ART
Relatively high levels of loss to 
follow-up at district hospital 
level and mortality at primary 
health centres while scaling up 
ART for universal access
Policy makers accepted the detrimental effect of 
ART payment on outcomes and the service 
began to be offered free-of-charge to all 
patients in Mbagathi Hospital 
Led to policy changes in the Kibera ART 
programme design and implementation to 
enhance ART uptake
Provided policy recommendations to reduce 
attrition rates
Assessing feasibility in speciﬁ  c populations or 
settings 
O’Brien et al.18 Universal access: the beneﬁ  ts 
and challenges in bringing integrated HIV 
care to isolated and conﬂ  ict-affected 
populations in the Republic of Congo
Zachariah et al.19 VCT and adjunctive 
cotrimoxazole reduces mortality in 
TB patients in Thyolo, Malawi
Wilson et al.20 HIV prevention, care and 
treatment in two prisons in Thailand 
Integrated ART can be offered in a 
conﬂ  ict setting with good 
outcomes
VCT and adjunctive cotrimoxazole 
shown to be feasible, safe and 
associated with reduced 
mortality in TB patients under 
programme conditions 
Describes the experience of 
offering HIV/AIDS care in two 
prisons in Thailand 
Provided knowledge on how to implement an 
integrated HIV/AIDS programme in a rural 
conﬂ  ict-affected setting to achieve universal 
access
Provided evidence on feasibility and effectiveness 
to support countrywide expansion of HIV 
testing and cotrimoxazole for TB patients in 
Malawi
Provided knowledge on how to implement HIV/
AIDS care in prison settings 
Advocating for policy change
Van Griensven et al.21 High prevalence of 
lipoatrophy among patients on stavudine-
containing ﬁ  rst-line ART in Rwanda
Grais et al.22 Unacceptably high mortality 
related to measles epidemics in Niger, 
Nigeria and Chad
Showed that lipoatrophy was an 
important complication of WHO 
recommended ﬁ  rst-line ART 
regimens 
Demonstrated unacceptably high 
measles-related case fatality in 
the three countries
Highlighted the urgent need for access to more 
affordable and less toxic ART regimens in Africa 
Provided evidence to advocate for improving 
measles vaccination programmes in the 
affected countries.
ART = antiretroviral treatment; HIV = human immunodeﬁ  ciency virus; AIDS = acquired immune-deﬁ  ciency syndrome; VCT = voluntary counselling and HIV 
testing; TB = tuberculosis; WHO = World Health Organization.
Table 3  Enabling factors for building operational research 
into an implementing organisation such as Médecins Sans 
Frontières
•  A critical mass of experienced and dedicated operational 
research staff who have programme skills and are available at 
headquarters and in the ﬁ  eld 
•  Headquarters staff includes a research ofﬁ  cer, a data manager 
and a medical editor, while in the ﬁ  eld operational research staff 
includes a research ofﬁ  cer or epidemiologist, a data manager 
and data entry clerks
•  A clear institutional policy framework has been written clarifying 
the ‘what, why and how’ of operational research 
•  Research planning, agenda setting, objectives, targets and 
budgeting are included in annual country project planning 
exercises 
•  Research questions are generated from the programmes, and 
research is conducted within the framework of ﬁ  eld operations 
and not run in parallel 
•  Training, strong mentorship and on-the-job supervision is 
provided to national staff, and close collaboration is established 
with local authorities and national partners
•  Prompt feedback of research results is given to the programmes 
and disseminated through publications in peer-reviewed 
journals, booklets and the on-line MSF Field Research Repository
•  An institutional ethics review board facilitates ethical review
•  Outputs are evaluated on a 6-monthly basis to assess 
performance and monitor results of research activity. 
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a change of treatment regimens from hospital-based, 
2-month intensive phase therapy centred around daily 
injections of streptomycin to oral, ambulatory treat-
ment given from health facilities or from family-based 
guardians;29 and a policy of routine HIV testing and 
counselling for all TB patients with provision of cotri-
moxazole preventive treatment to those found to be 
HIV-positive.30–33
Despite the achievements, not all the OR was suc-
cessful. Several projects started and implemented with 
the NTP funding were never completed because of 
poor study design or poor, unreliable data collection, 
Table 4  Barriers to operational research in Médecins Sans Frontières, possible reasons and lessons learnt. Adapted from 
Zachariah et al.12
Barriers to operational research Possible reasons Lessons learnt
Perceptions and lack of awareness 
about the role of research 
Senior managers fear that operational 
research will divert resources from 
aid delivery
Lack of knowledge about the role 
and relevance of applied research 
to ﬁ  eld operations 
Weak knowledge translation 
strategy for operational research 
within the organisation
Establishing an institutional policy framework and 
reference document for operational research reassures 
operations staff and guides research activities
Research resources are complementary (e.g., a statistician 
or data clerk cannot do the work of a nurse) 
The MSF Field Research Repository (http://ﬁ  eldresearch.
msf.org) raises awareness about research activity and 
its impact on country health policies
Time and opportunity 
Operations ﬁ  eld and headquarters 
staff have no dedicated time or 
opportunity for research activity, 
especially related to protocol 
development, data analysis or 
writing papers. 
No one to manage research activity 
at headquarters or in the ﬁ  eld 
Research is an additional 
responsibility for already 
overworked senior staff
No dedicated budget or human 
resources for research 
implementation
Provide dedicated human resources for operational 
research at headquarters and in the ﬁ  eld to support 
research activities
Include budgets and additional human resources needed 
for research during the annual operational planning 
exercise
Give staff dedicated time (e.g., 2 days per week) to 
conduct research
Lack of human resource capacity 
Inadequate research capacity among 
MSF staff 
Individuals in charge of research 
have limited research or 
programme skills 
Capacity building efforts are 
targeted at the wrong people 
Rapid turnover of staff
Establish strict criteria for selection of potential 
candidates for training
Persons involved with research have to accept contracts 
of at least 3 years
Introduce the concept of research fellows
Study design and implementation 
The research question is not relevant 
to programme implementation
Poor adherence to research protocol 
Poor quality of data or too much data
The researcher has inadequate 
understanding or experience 
working at programme level 
(programme skills)
Inadequate on-the-job training and 
supervision
Poorly designed data collection 
tools
Regularly provide ongoing mentoring and improved 
supervision in deﬁ  ning the study question, the studies 
themselves and data tools 
Review data on a regular basis
Ethics clearance 
No ethics clearance is sought or 
received
Programme staff conclude that no 
ethics clearance is required
Perception that ethics committees 
are a burden
No functional ethics review board 
exists in the setting 
Establishment of an MSF Ethics Review Board facilitates 
ethical clearance 
Make ethics an essential part of training to promote the 
perception that ethical boards are allies and not 
adversaries
Writing skills for publication
Failure of research to lead to 
publication
Poorly designed studies
Inadequate writing and language 
skills 
No ethics clearance or exemption
No interest in investing efforts for 
publication in scientiﬁ  c journals
Development of writing skills training for publication 
with the support of a medical editor(s) through 
workshops and mentoring
Emphasis at senior level on the importance of research 
publications
Policy and practice 
Research ﬁ  ndings are not translated 
into policy and practice at the 
ﬁ  eld level
Key decision and policy makers are 
not involved from the start and 
thus lack ownership
Study authorship is not inclusive of 
key decision makers
MSF workers lack the skills to 
interact with national authorities 
and partners
Involve decision makers and local partners in developing 
studies from the beginning to encourage ownership of 
the results
Selected operational research ofﬁ  cers should have both 
research and programme management skills and have 
longer term contracts (e.g., 3 years) 
Introduce a clear performance framework with indicators 
to evaluate the impact of research on policy and 
practice over time 
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and there was sometimes a failure to translate com-
pleted but complex projects into understandable and 
readable papers. Sometimes the research was com-
pleted and published showing that an intervention 
was feasible and useful,34 yet for various reasons, 
policy and practice remained unchanged. Failures are 
inevitable in any endeavour, but because these involve 
funds, human resource time and energy, it is impor-
tant to learn from mistakes. 
CAPACITY BUILDING
Translating an important research question into a 
published paper and using the fi  ndings to infl  uence 
policy and practice is a long, hard journey that re-
quires time, capacity and perseverance (Figure 3). In 
many programme settings this capacity and time are 
often lacking, but if they are included as an essential 
part of the programme they can be accomplished. 
The Union has for many years modelled its OR 
training programmes on its successful guide ‘Research 
Methods for Lung Health’.35  Union training pro-
grammes have ranged from 3-day refresher training 
programmes on OR methods to 2-week protocol de-
velopment workshops. These are similar in design to 
OR courses run by the US Centers for Disease Con-
trol and Prevention, where over the course of 10 years 
large numbers of TB programme and laboratory staff 
have been trained in OR methods.36 However, ques-
tions are rightly being asked about whether these 
training methods lead to the creation of sustainable, 
research leadership in programmatic OR with publi-
cation of completed studies in peer-reviewed journals. 
For example, at the International TB Training Course 
in Japan, with the assistance of external facilitators 
28 participants developed OR projects over a 7-year 
period between 2001 and 2007, none of which re-
sulted in the publication of a scientifi  c paper.37 New 
paradigms are clearly needed, and The Union has pre-
viously experimented, and is currently experimenting, 
with several different approaches. 
First, The Union used to run a junior consultant 
programme that included training on how to perform 
technical assistance, training and OR. Three physi-
cians from low-income countries attended a Union-
sponsored OR methods course, and were then linked 
to their NTP and tasked with developing an OR proj-
ect that addressed country-relevant issues. However, 
given that they were not formally employed by the gov-
ernment, it was diffi  cult to obtain country ‘buy-in’, 
Figure 2  Research planning in the Malawi NTP. NTP = 
N  ational Tuberculosis Programme; WHO = World Health Or-
ganization; LSTM = Liverpool School of Tropical Medicine; 
NGO = non-governmental organisation; MSF = Médecins Sans 
Frontières; AIDS = acquired immune-deﬁ  ciency syndrome; TB = 
tuberculosis.
Table 5  Key factors that enabled operational research within 
the Malawi NTP
•  There was a well-functioning TB programme with countrywide, 
standardised case ﬁ  nding, treatment and monitoring systems
•  Research studies addressed constraints in TB control, and used 
established TB systems
•  An annual research programme and research activities were 
planned within the NTP, included in the annual workplan and 
approved each year by the NTP Steering Group
•  A good relationship was established with the Malawi National 
Health Science Research Committee that received and approved 
the annual research plan and programme before the start of 
the forthcoming year, and in turn expected an end-of-year 
report
•  There was a Central Unit Ofﬁ  cer responsible for operational 
research
•  There was a dedicated budget line for research
•  Resources were allocated to training that included an annual 
research training workshop, an annual writing skills workshop 
and an annual review meeting to disseminate research ﬁ  ndings 
to national and international stakeholders
•  Once research studies were completed, they were quickly 
translated into reports and papers, many of which were 
subsequently published in international peer reviewed journals
•  Research publications from the Malawi NTP were collated each 
year into an annual report that was printed and disseminated to 
all districts in the country. 
NTP = National TB Control Programme; TB = tuberculosis. Figure 3  The steps from research question to scientiﬁ  c paper.Operational   research   in   The   Union   and   MSF  151
cooperation and ownership of the process. In another, 
similar initiative, after the presentation of a situational 
analysis of why HIV testing uptake was suboptimal 
among TB patients, participants at a Union-sponsored 
OR course in Uganda developed a research protocol 
to address the issue in fi  ve of the country’s districts. 
After the course, a Union-sponsored consultant was 
mentored and tasked with refi  ning the protocol, ob-
taining country and Union institutional board ap-
proval, developing the questionnaire, training staff, 
collecting and analysing data with country colleagues, 
submitting abstracts and writing papers. Two of these 
were accepted in peer-reviewed journals and helped 
to change country practice. 
Second, The Union has received funding to engage 
OR fellows, appointed using strict selection criteria, 
who work within disease control programmes in their 
countries. They work full- or part-time for The Union 
and are given support and time from the programmes 
to carry out relevant OR. By June 2010, eight OR fel-
lows had been placed in six countries (Viet Nam, In-
dia, Malawi, Zimbabwe, South Africa and Brazil). 
They receive training and mentorship from research-
ers at The Union in collaboration with their country 
colleagues, and are expected to initiate, complete and 
write up OR. One of the key milestones of these fel-
lowships is the submission of two papers to peer-
r  eviewed journals by the end of a 12-month period, 
failure to achieve this resulting in termination of the 
contract. Four of the fellows had completed their fi  rst 
12-month contracts by the beginning of June 2010, 
and each had submitted two or more papers to earn a 
second 12-month contract. 
Third, a new training course has been developed in 
partnership with MSF-Luxembourg that consists of 
three modules of 1 week each, spread over 9 months, 
with clearly defi  ned outputs for each module.10 The 
success or otherwise of this course is judged by a mea-
surable product: completed projects that are submit-
ted to and published in peer-reviewed journals, dem-
onstrating that the participants can take a research 
question through to research protocol, research im-
plementation, data analysis and writing up and pub-
lication of a scientifi  c paper. 
Fourth, the TREAT TB efforts focus on country-
based OR training linked to programme priority re-
search questions with both mentoring support and 
necessary fi  nancial resources to undertake research 
activities. The training includes the development of 
research protocols, along with the basic method-
ological skills necessary to carry out the research. The 
duration of the training has been limited to 5 days 
(Table 6) to ensure the most effi   cient use of pro-
gramme staff time and resources. Once a workshop is 
completed, clear timelines and expectations for study 
implementation are created. Technical support is pro-
vided for activities ranging from ethics reviews, study 
implementation and statistical analysis to peer-reviewed 
publication. Finally, tracking the impact of the coun-
try research efforts in terms of national, regional and 
global policy change is an essential component of 
TREAT TB.
MSF has three key approaches to OR training. 
First, there is ‘on-the-job’ training at project level. 
S  enior-level researchers with doctorates hardly ever 
work with MSF, due to the rather modest conditions 
of service and employment settings. The emphasis has 
thus been to try and develop capacity in either expa-
triate or national fi  eld staff. Promising individuals are 
sponsored for courses on public health, medical sta-
tistics and data management. They are then taken 
through the practical process of defi  ning  research 
questions, writing protocols, managing and analysing 
Table 6  Workshop agenda of the TREAT TB course run in 
India in 2009
Day 1 By the end of the day, the participants will have:
• Identiﬁ  ed and recorded the research question 
•  Written a rationale for why this is important
09:30–10:15 Inaugural session: Introductions
10:45–11:45 Lecture: Introduction to protocol development 
11:45–12:30 Lecture: The research question 
12:30–13:15 Lecture: Justifying the need for research 
14:00–16:00 Protocol: Setting the framework and deﬁ  ning the 
null hypothesis
16:15–17:30 Protocol: Preparing the rationale of the study
Day 2  By the end of the day, the participants will have:
•  Recorded the study design selected
•  Described the population to be studied
09:30–11:00 Lecture: Using epidemiology and designing the 
research 
11:30–13:00 Lecture: Identifying the population for study
14:00–15:45 Protocol: Selecting the study design
16:15–17:30 Protocol: Describing the population
Day 3 By the end of the day, the participants will have:
• Deﬁ  ned the variables to be measured
•  Outlined how information is going to be 
collected
09:30–11:00 Lecture: Variables and their deﬁ  nition
11:30–13:00 Lecture: Measuring and recording 
14:00–15:30 Protocol: Deﬁ  ning the variables
16:00–17:30 Protocol: Methods and measurements
Day 4 By the end of the day, the participants will have:
•  Explained how information will be analysed 
•  Indicated errors and how to avoid them
• Deﬁ  ned the ethical issues to be addressed 
• Speciﬁ  ed how the research will be conducted
09:30–11:00  Lecture: Comparing, analysing and deﬁ  ning error 
and bias 
11:30–13:00 Lecture: Ethical and practical issues 
14:00–15:30 Protocol: Comparing groups, avoiding error 
and bias
16:00–17:30 Protocol: Finalising workplan and budget
Day 5 By the end of the day, the participants will have:
•  Presented the protocol for critical review by 
peers
09:30–10:30 Lecture: Managing the research 
11:00–13:30 Protocol: Presentation of research protocol
14:30–15:45 Protocol: Presentation of research protocol
16:00–17:30 Protocol: Presentation of research protocol
17:30–18:00 Concluding session
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data and writing manuscripts for publication. The pil-
lar of this approach is strong and sustained mentor-
ship by the OR unit, which is staffed by experienced 
researchers, epidemiologists and medical editors. There 
has recently been increased emphasis on training na-
tional staff due to rapid turnover of expatriates. This 
model of training has been successfully conducted in 
fi  ve countries, namely Malawi, Kenya, Cambodia, Thai-
land and India.
Second, MSF invests in ‘writing skills for publica-
tion’ through workshops led by an experienced medi-
cal editor. Most individuals with Master of Public 
Health degrees or basic statistical training can collect, 
manage and analyse programme data. The real chal-
lenge lies in translating the fi  ndings into a manuscript 
that is accepted for publication. Specifi  c writing skills 
workshops coupled with mentoring support have been 
instrumental at enhancing publication capacity both 
at headquarters and in the fi  eld. Figure 4 shows the 
trend over time in peer-reviewed scientifi  c publica-
tions in the MSF Operational Centre, Brussels, and 
the impact of having a critical mass of headquarter 
staff providing mentorship support. 
The third, rather novel, approach is the joint train-
ing course developed with The Union, described ear-
lier. MSF also plans to introduce the concept of OR 
fellowships for its own staff, as this is likely to en-
hance retention and provide better career prospects. 
If partnered with a university, such a fellowship pro-
gramme might lead to enhanced degree status and in-
crease MSF’s own research capacity. 
ETHICS
Ethics has always been an important component of 
research promoted by both The Union and MSF. Both 
organisations have ethics review boards with terms of 
reference and policy and operational guidelines.13,38 
MSF has recently published its experience of research 
ethics reviews in humanitarian contexts.39 Both ethics 
committees follow the principles set out in the Decla-
ration of Helsinki, adopted by the World Medical 
Association (WMA) in 1964 and last revised at the 
59th WMA General Assembly in October 2008.40 In 
addition to ensuring ethical standards in research, 
the ethics committees foster discussion and refl  ection 
on ethical issues in all areas of work in which their 
respective organisations are involved. The Union’s 
Ethics Advisory Group (EAG) has recently updated 
its own standard operating procedures on research 
protocol reviews and the promotion of ethical stan-
dards and issues in lung health services and inter-
national development (see http://www.theunion.org/
ethics-a  dvisory-group-eag.html).
Protocols developed by the OR Fellows and from 
the OR Course participants are subjected to review 
by The Union EAG, as are research protocols sup-
ported under the TREAT TB Initiative. Formal ethics 
review of OR proposals emphasises the need for in-
formed consent to prevent risks to participants, data 
confi   dentiality, the need to submit for local ethics 
committee approval and the need to provide study 
results to local communities in accessible formats. 
Proposals for studies on existing data focus on the 
latter three items. 
CONCLUSION
We strongly believe that OR should be an integral part 
of routine programme activities in low- and middle-
income countries. If it is linked to routine programme 
monitoring and evaluation, OR can strengthen pro-
gramme activities and lead to improved performance 
and better health prevention and care for patients. 
What is needed is further development of OR capac-
ity, allocation of specifi  c resources and collaboration 
between different actors such as international and na-
tional academic institutions, national programme 
managers and NGOs who should work together in 
promoting OR.5
There are encouraging signs of progress. The 
Global Fund to Fight AIDS, Tuberculosis and Malaria 
requests that countries include up to 10% of their 
funding for monitoring, evaluation and OR,41 and 
this should be a major source of the funding needs for 
fi  eld activities. In July 2009, the Wellcome Trust an-
nounced the formation of seven new international 
consortia, each led by an African institution, as a step 
forward in strengthening research capacity on the 
A  frican continent.42 OR needs to be embedded in the 
research platforms that are being developed. In De-
cember 2009, the WHO organised a Stop TB Sympo-
sium at the 40th Union World Conference on Lung 
Health in Cancun, Mexico, a large portion of which 
was devoted to the role of OR in addressing TB and 
poverty. In late 2009 and early 2010, the United States 
government, through its new Global Health Initiative 
that will serve as the guiding framework for all of the 
government’s health-related efforts, highlighted the 
role and importance of OR and the use of fi  ndings to 
Figure 4  Trend in peer-reviewed scientiﬁ  c  publications  in 
M  édecins Sans Frontières Operational Centre Brussels (1997–
2009) and the impact of dedicated staff providing mentorship 
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‘identify critical problems and improvements’.43 The 
WHO convened an international meeting in May 
2010 of interested stakeholders and donors to discuss 
the priorities for OR in TB control and the steps needed 
to develop the necessary capacity to move the agenda 
forward. In all these efforts, The Union and MSF are 
committed to playing their full part in working to-
gether with stake holders, including the WHO, to turn 
the vision of better OR into reality on the ground. 
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La recherche opérationnelle est devenue un sujet 
d’actualité dans les réunions nationales, les conférences 
internationales et les forums de donateurs. L’Union In-
ternationale contre la Tuberculose et les Maladies Respi-
ratoires (L’Union) ainsi que le Centre Opérationnel de 
Médecins Sans Frontières (MSF) à Bruxelles suscitent 
énergiquement et mettent en œuvre la recherche opéra-
tionnelle (OR) avec des collègues des pays à revenus 
faibles ou moyens. Dans cet article, nous décrivons com-
ment les deux organisations défi  nissent l’OR et nous ex-
pliquons les principes de guidance et la méthodologie 
qui étayent la stratégie du développement et de l’expan-
sion des OR dans ces pays. Nous articulons les approches 
de L’Union et de MSF dans leur soutien à l’OR, en insis-
tant sur les principales synergies et différences. Dès lors, en 
uti  lisant comme exemple le Programme National de lutte 
contre la Tuberculose du Malawi, nous montrons com-
ment l’OR peut être intriquée avec les activités de lutte 
contre la tuberculose, entraînant des modifi  cations de 
la politique et des pratiques au niveau national. Nous 
discutons du problème diffi  cile et pourtant d’une impor-
tance vitale du développement des aptitudes et nous 
partageons nos visions sur le nouveau paradigme d’une 
formation liée au produit et de la solidarité dans une 
OR basée sur les performances comme deux moyens de 
développement des compétences nécessaires au niveau 
national pour garantir qu’une recherche soit effective-
ment pratiquée. Finalement, nous mettons en évidence 
la nécessité de considérer les composantes éthiques de 
l’OR et de les incorporer dans la pratique. Il s’agit d’un 
élément-clé à impliquer dans l’OR. Nous sommes con-
fi  ants que lors du partenariat avec les responsables inté-
ressés, y compris l’Organisation Mondiale de la Santé, 
nous pourrons stimuler la mise en œuvre d’une OR per-
tinente et de bonne qualité comme élément intégral de la 
fourniture de services de santé, qui à son tour contribuera 
à une amélioration de la santé des populations, particu-




La investigación operativa (OR) se ha convertido en un 
tema de mucha actualidad en las reuniones nacionales, 
las conferencias internacionales y los foros de donantes. 
La Unión Contra el Tuberculosis y Enfermedades Respi-
ratorias (La Unión) y el centro operativo de Médecins 
Sans Frontières (MSF) en Bruselas fomentan en forma 
decidida y ponen en práctica l’OR con profesionales de 
países de medianos y bajos ingresos. En el presente artí-
culo se describe la forma como ambas organizaciones 
defi  nen la OR y se explican los principios conductores 
y los métodos que respaldan la estrategia de estableci-
miento y ampliación de este tipo de investigación en esos 
países. Se aclara el enfoque de respaldo a la OR de La 
Unión y de MSF y se ponen en evidencia los principales 
sinergismos y las diferencias. Luego, se toma como ejem-
plo el Programa Nacional contra la Tuberculosis en Ma-
lawi y se destaca el mecanismo de integración de la OR 
a las actividades de control de la tuberculosis, con el fi  n 
de alcanzar cambios en las políticas y las prácticas a es-
cala nacional. Se analiza el aspecto delicado y al mismo 
tiempo primordial de la creación de capacidad de acción 
y se comunica un punto de vista sobre el nuevo para-
digma de las becas de capacitación basada en los pro-
ductos y la OR basada en el rendimiento, como meca-
nismos de desarrollo de las competencias nacionales 
necesarias, con el fi  n de verifi  car la ejecución real de la 
investigación en el terreno. Por último, se pone en relieve 
la importancia de considerar e incorporar en la práctica 
los componentes éticos de la OR. Este es un momento 
crucial para participar en la OR. Se espera que la vincu-
lación de interesados directos como la Organización 
Mundial de la Salud logre fomentar la realización de una 
OR pertinente y de excelente calidad, como parte inte-
grante de la prestación de servicios de salud. Esto re-
dundará a su vez en una mejor salud para los pueblos, 
sobre todo en las regiones más pobres del mundo.